Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

International Journal of Clinical Oncology

Issue 3/2026

Content (20 Articles)

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; imlunestrant for breast cancer, tafasitamab for follicular lymphoma, atezolizumab for thymic carcinoma, retifanlimab for anal canal squamous cell carcinoma, and tagraxofusp for blastic plasmacytoid dendritic cell neoplasm

Noriomi Matsumura

Genetic and molecular mechanisms in lung cancer with interstitial pneumonia

Aya Fukuizumi, Masahiro Seike

Molecular analysis of tumor recurrence using established cancer stem cell-line and drug discovery

Kiyotaka Nakano, Eiji Oki, Masaki Yamazaki, Masami Suzuki, Shigeto Kawai, Yoko Zaitsu, Chiyoko Nishime, Koji Ando, Genta Nagae, Norifumi Harimoto, Mitsuhiko Ota, Tetsuro Kawazoe, Kentaro Nonaka, Keita Natsugoe, Sachie Omori, Hiroshi Saeki, Hiroyuki Aburatani, Tatsumi Yamazaki, Yoshihiko Maehara

Prevalence of sarcopenia in esophageal cancer patients receiving preoperative neoadjuvant therapy: a systematic review and meta-analysis

Mohamed Abosheisha, Mohamed Abdellatif, Muhammed Kandeel, Ahmed Alemam, Ahmad Asaad, Md Abdus Samad Hasan, Mustafa Alqasem, Abdelrahman Abdelaal, Momen Abdelglil, Mohamed Terra, Ahmed Swealem, Mohamed Ismaiel, Jeremy Wilson, Conor Magee

Reassessing prognostic markers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors: the enduring value of body composition, nutritional, and inflammatory indices

Norihiko Tsuchiya, Sei Naito, Hiroki Fukuhara, Hayato Nishida, Mayu Yagi, Yuki Takai, Atsushi Yamagishi, Takafumi Narisawa, Shinta Suenaga

Real-world effectiveness and safety of lisocabtagene maraleucel for relapsed/refractory large B cell lymphoma in Japan

Tetsuro Ochi, Shinichi Makita, Anna Hiratsuka, Risa Nishiyama, Kimiteru Ito, Akiko Miyagi Maeshima, Wataru Takeda, Noriko Iwaki, Suguru Fukuhara, Wataru Munakata, Koji Izutsu

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma

Eiji Kikuchi, Michiel S. Van der Heijden, Begoña P. Valderrama, Shilpa Gupta, Jens Bedke, Sang Joon Shin, Jian-Ri Li, Jun Guo, Pongwut Danchaivijitr, Ravindran Kanesvaran, Se Hoon Park, Wen-Pin Su, Shuya Kandori, Woo Kyun Bae, Alvin Wong, Seema Gorla, Abhishek Bavle, Xuesong Yu, Yi-Tsung Lu, Thomas Powles

Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective study

Kazuhisa Kitami, Shiho Kuji, Natsuko Kamiya, Hiroko Machida, Junki Koike, Reiko Watanabe, Takeshi Hirasawa, Nao Suzuki, Etsuko Miyagi, Kazuyoshi Kato

Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma

Shinichi Makita, Koji Izutsu, Yuko Mishima, Takahiro Kumode, Junya Kuroda, Nobuhiro Kanemura, Noriko Fukuhara, Kazuyuki Shimada, Chiemi Mori, Atsuko Kawasaki, Takeshi Miyake, Dai Maruyama

Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatment

Eriko Takatori, Tadahiro Shoji, Ami Jo, Miku Musashi, Shunsuke Tatsuki, Nanako Jonai, Yohei Chiba, Sho Sato, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Fumiaki Takahashi, Takeshi Aida, Tsukasa Baba

Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer

Sho Sato, Masahiro Kagabu, Ami Jo, Haruka Otsuka, Ayaka Kitamura, Miku Musashi, Nanako Jonai, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Tadahiro Shoji, Tsukasa Baba

18F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatment

Shiori Murata, Yusaku Moribata, Shusuke Akamatsu, Aki Kido, Yuki Himoto, Yasuhisa Kurata, Tomoaki Otani, Takayuki Sumiyoshi, Ryoichi Saito, Takashi Ogata, Rihito Aizawa, Kiyonao Nakamura, Takashi Mizowaki, Yuji Nakamoto, Takashi Kobayashi, Takayuki Goto

Lack of molecular mimicry between HPV vaccine L1 antigen and human proteins by a computational analysis

Kazuhiro Nishioka, Kentaro Sekiyama, Reona Shiro, Ikuo Tsunoda, Noriomi Matsumura

Pulmonary metastasectomy from bone and soft tissue sarcomas: defining surgical indications at the time of second pulmonary recurrence

Daichi Kakibuchi, Satoru Okada, Tatsuo Furuya, Masanori Shimomura, Chiaki Nakazono, Satoshi Teramukai, Ryu Terauchi, Toshiharu Shirai, Kenji Takahashi, Masayoshi Inoue

Real-world clinical utility and challenges of comprehensive genomic profiling for advanced solid tumors in a community health institution

Mihoko Doi, Nobuhisa Ishikawa, Katsunori Shinozaki, Kanako Iwami, Hanae Satano, Kunitomo Imazu, Midori Noma, Yuko Shiroyama, Mitsuru Kajiwara, Toshihiro Matsuo, Tomoyuki Akita, Takashi Nishisaka, Toshiyuki Itamoto

Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trial

Hideo Shigematsu, Tomomi Fujisawa, Fumikata Hara, Hiroji Iwata, Toshiyuki Ishiba, Yukinori Ozaki, Takehiko Sakai, Yasuaki Sagara, Akihiko Shimomura, Kazuki Sudo, Kaori Terata, Yoichi Naito, Kazuki Nozawa, Keita Sasaki, Noriko Mitome, Ryo Sadachi, Taro Shibata, Tadahiko Shien

Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer: a systematic review and meta-analysis

Maki Umemiya, Kazuhiro Kou, Yoshihide Inayama, Jun Kamei, Ken Yamaguchi, Yoshie Yamada, Takahiro Itaya, Yosuke Yamamoto, Masaki Mandai, Yusuke Ogawa

Optimizing pelvic lymph node dissection in bladder cancer: obturator focus, pN1 prognosis, and sentinel node feasibility

Jun Miki, Shoji Kimura, Fumihiko Urabe, Mahito Atsuta, Kosuke Iwatani, Kazuhiro Takahashi, Naoki Uchida, Hirokazu Kagawa, Naoya Tomomasa, Shun Saito, Wataru Fukuokaya, Akihiro Matsukawa, Keiichiro Mori, Takafumi Yanagisawa, Shunsuke Tsuzuki, Takahiro Kimura

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study

Yoshitaka Kaido, Masahiro Kagabu, Yohei Chiba, Sho Sato, Eriko Takatori, Takayuki Nagasawa, Tadahiro Shoji, Manami Sakurai, Tatsuhiko Shigeto, Kenichi Makino, Tsuyoshi Ohta, Shogo Shigeta, Tomoyuki Nagai, Michiko Kaiho-Sakuma, Hidemichi Watari, Satoru Nagase, Hideki Tokunaga, Tsukasa Baba, Yoshihito Yokoyama

Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology

  • Open Access
  • Correction

Kotaro Suzuki, Hideaki Miyake, Anri Inaki, Shoko Takano, Yasutoshi Kuboki, Takashi Mizowaki, Katsumasa Nakamura, Makoto Ueno, Shigemi Matsumoto, Daisuke Obinata, Tohru Nakagawa, Masato Murakami, Yoshiyuki Majima, Megumu Yokono, Masao Namba, Takayuki Yoshino

Feb 26
Issue: 2/2026
Apr 26
Issue: 4/2026

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Case simulations: Biomarker-driven management of NSCLC (Link opens in a new window)

Do you want to assess your biomarker testing skills and management decisions? Use these simulation-based case studies based on realistic NSCLC scenarios to do so in a practical and secure environment.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
COMMISSIONED

How-to guide for healthcare professionals: understanding genomic reports

This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only. 

Genomic testing helps inform cancer diagnosis, prognosis, and treatment. A genomic report is generated by the laboratory carrying out next-generation sequencing to analyze biopsy samples. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.

NP-GB-106631 | Jan 2026

Commissioned by:
  • Boehringer Ingelheim
Learn more
Image Credits
Biomarker-driven management of NSCLC logo/© Springer Health+ IME, DNA double helix structure on a purple background/© 2025 Adobe